giotrif film-coated tablets 30mg
boehringer ingelheim singapore pte. ltd. - afatinib dimaleate 44.3400mg eqv afatinib - tablet, film coated - 30.0000mg - afatinib dimaleate 44.3400mg eqv afatinib 30.0000mg
giotrif film-coated tablets 40mg
boehringer ingelheim singapore pte. ltd. - afatinib dimaleate 59.1200mg eqv afatinib - tablet, film coated - 40.0000mg - afatinib dimaleate 59.1200mg eqv afatinib 40.0000mg
giotrif film-coated tablets 50mg
boehringer ingelheim singapore pte. ltd. - afatinib dimaleate 73.9000mg eqv afatinib - tablet, film coated - 50.0000mg - afatinib dimaleate 73.9000mg eqv afatinib 50.0000mg
spiolto respimat
boehringer ingelheim (nz) limited - olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation; tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation - solution for inhalation - 2.5mcg/2.5mcg - active: olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiolto respimat is indicated for the long term, once daily maintenance treatment in patients with copd (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, and to reduce associated dyspnoea.
spiriva
boehringer ingelheim (nz) limited - tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium - powder filled inhalation capsule - 18 mcg - active: tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium excipient: gelatin lactose monohydrate - spiriva is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.
giotrif 20 mg
boehringer ingelheim israel ltd. - afatinib as dimaleate - film coated tablets - afatinib as dimaleate 20 mg - afatinib - giotrif as monotherapy is indicated for the treatment of: • egfr tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);• locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.
giotrif 30 mg
boehringer ingelheim israel ltd. - afatinib as dimaleate - film coated tablets - afatinib as dimaleate 30 mg - afatinib - giotrif as monotherapy is indicated for the treatment of: • egfr tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);• locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.
giotrif 40 mg
boehringer ingelheim israel ltd. - afatinib as dimaleate - film coated tablets - afatinib as dimaleate 40 mg - afatinib - giotrif as monotherapy is indicated for the treatment of: • egfr tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);• locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.
giotrif 50 mg
boehringer ingelheim israel ltd. - afatinib as dimaleate - film coated tablets - afatinib as dimaleate 50 mg - afatinib - giotrif as monotherapy is indicated for the treatment of: • egfr tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);• locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.
twynsta tablet 40mg10mg
boehringer ingelheim singapore pte. ltd. - amlodipine besilate 13.870mg eqv amlodipine; telmisartan - tablet - 10mg - amlodipine besilate 13.870mg eqv amlodipine 10mg; telmisartan 40mg